Sex-specific autistic endophenotypes induced by prenatal exposure to valproic acid involve anandamide signalling.

These findings highlight sexually dimorphic consequences of prenatal VPA exposure that may be related to sex-specific effects of VPA on endocannabinoid neurotransmission in the course of development and introduce a new therapeutic target for reversing autistic-like symptoms in both sexes.